Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dong-Joo Cheon

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Oncogenesis|July 2, 2025
Lipid droplet-associated hydrolase (LDAH) knockdown enhances TAG hydrolysis and promotes ovarian cancer progression and chemoresistanceBhawna Deswal, Sameera Nallanthighal, Elahe Nikpayam, et al.
Nano Letters|March 24, 2018
Intracellular Delivery of Nanomaterials via an Inertial Microfluidic Cell HydroporatorYanxiang Deng, Megan Kizer, Miran Rada, et al.
Oncogene|May 18, 2018
Inhibitor of apoptosis proteins (IAPs) mediate collagen type XI alpha 1-driven cisplatin resistance in ovarian cancerMiran Rada, Sameera Nallanthighal, Jennifer Cha, et al.
Carcinogenesis|May 1, 2015
ADAM12 is a prognostic factor associated with an aggressive molecular subtype of high-grade serous ovarian carcinomaDong-Joo Cheon, Andrew J Li, Jessica A Beach, et al.
Oncotarget|September 17, 2016
FOXC2 augments tumor propagation and metastasis in osteosarcomaMaricel C Gozo, Dongyu Jia, Paul-Joseph Aspuria, et al.
Plos One|March 6, 2009
CA125/MUC16 is dispensable for mouse development and reproductionDong-Joo Cheon, Ying Wang, Jian Min Deng, et al.
Oncotarget|December 31, 2015
Sphingosine kinase 1 is required for TGF-β mediated fibroblastto- myofibroblast differentiation in ovarian cancerJessica A Beach, Paul-Joseph P Aspuria, Dong-Joo Cheon, et al.
Experimental Cell Research|May 8, 2020
HOXB13 controls cell state through super-enhancersPaul-Joseph Aspuria, Dong-Joo Cheon, Maricel C Gozo, et al.
The Journal of Pathology. Clinical Research|August 9, 2016
Differential expression of argininosuccinate synthetase in serous and non-serous ovarian carcinomasDong-Joo Cheon, Ann E Walts, Jessica A Beach, et al.
Cancers|October 13, 2021
Heat Shock Protein 27, a Novel Downstream Target of Collagen Type XI alpha 1, Synergizes with Fatty Acid Oxidation to Confer Cisplatin Resistance in Ovarian Cancer CellsJames Patrick Heiserman, Sameera Nallanthighal, Cody C Gifford, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Oncogenesis|July 2, 2025
Lipid droplet-associated hydrolase (LDAH) knockdown enhances TAG hydrolysis and promotes ovarian cancer progression and chemoresistanceBhawna Deswal, Sameera Nallanthighal, Elahe Nikpayam, et al.
Nano Letters|March 24, 2018
Intracellular Delivery of Nanomaterials via an Inertial Microfluidic Cell HydroporatorYanxiang Deng, Megan Kizer, Miran Rada, et al.
Oncogene|May 18, 2018
Inhibitor of apoptosis proteins (IAPs) mediate collagen type XI alpha 1-driven cisplatin resistance in ovarian cancerMiran Rada, Sameera Nallanthighal, Jennifer Cha, et al.
Carcinogenesis|May 1, 2015
ADAM12 is a prognostic factor associated with an aggressive molecular subtype of high-grade serous ovarian carcinomaDong-Joo Cheon, Andrew J Li, Jessica A Beach, et al.
Oncotarget|September 17, 2016
FOXC2 augments tumor propagation and metastasis in osteosarcomaMaricel C Gozo, Dongyu Jia, Paul-Joseph Aspuria, et al.
Plos One|March 6, 2009
CA125/MUC16 is dispensable for mouse development and reproductionDong-Joo Cheon, Ying Wang, Jian Min Deng, et al.
Oncotarget|December 31, 2015
Sphingosine kinase 1 is required for TGF-β mediated fibroblastto- myofibroblast differentiation in ovarian cancerJessica A Beach, Paul-Joseph P Aspuria, Dong-Joo Cheon, et al.
Experimental Cell Research|May 8, 2020
HOXB13 controls cell state through super-enhancersPaul-Joseph Aspuria, Dong-Joo Cheon, Maricel C Gozo, et al.
The Journal of Pathology. Clinical Research|August 9, 2016
Differential expression of argininosuccinate synthetase in serous and non-serous ovarian carcinomasDong-Joo Cheon, Ann E Walts, Jessica A Beach, et al.
Cancers|October 13, 2021
Heat Shock Protein 27, a Novel Downstream Target of Collagen Type XI alpha 1, Synergizes with Fatty Acid Oxidation to Confer Cisplatin Resistance in Ovarian Cancer CellsJames Patrick Heiserman, Sameera Nallanthighal, Cody C Gifford, et al.
Pageof 3